| Financial Year |
March 31 2023 |
| Monetary Funds |
2,525,294,995.76 |
| Held-for-trading Financial Assets |
101,393,939.40 |
| Notes Receivable |
2,147,693.10 |
| Accounts Receivable |
1,487,139,539.17 |
| Advances to Suppliers |
52,263,888.30 |
| Other Receivables |
44,593,236.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,369,149,879.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
62,635,261.85 |
| Total Current Assets |
6,715,573,675.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,404,123.73 |
| Investment Properties |
37,509,378.11 |
| Fixed Assetes |
1,656,828,731.78 |
| Under-construction Projects |
8,005,574.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
426,158,689.45 |
| R&D expenses |
-- |
| Goodwill |
190,707,889.50 |
| Long-Term Deferred and Prepaid Expenses |
31,446,737.59 |
| Deferred Income Tax Assets |
39,931,258.72 |
| Other Non-Current Assets |
31,778,639.39 |
| Sub-Total of Non-Current Assets |
2,522,194,245.06 |
| Total Assets |
9,237,767,920.74 |
| Short-Term Loans |
50,813,733.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,476,786,735.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
106,521,098.14 |
| Taxes Payable |
79,794,341.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
292,313,627.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,097,952.27 |
| Other Current Liabilities |
51,187,103.75 |
| Sub-Total of Current Liabilities |
2,506,399,425.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
55,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,441,150.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
160,348,555.52 |
| Total Liabilities |
2,666,747,981.12 |
| Paid-In Capital(Or Share Stock) |
547,397,500.00 |
| Capital Surplus |
237,894,112.21 |
| Surplus Reserve |
238,324,742.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,301,065,254.21 |
| Minority Stockholder's Interest |
155,448,190.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,415,571,748.72 |
| Owner's Equity（Stockholder's Equity） |
6,571,019,939.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,237,767,920.74 |
